Clinical Trials Browser

Phase 2 × Bosentan × 90 days × Clear all

NCT01009177 2026-06-03

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)

Phase 2 Completed

Melanoma, Neoplasm Metastasis